BGI-Shenzhen has again extended the deadline for its tender offer to acquire Complete Genomics...

BGI-Shenzhen has again extended the deadline for its tender offer to acquire Complete Genomics (GNOM+1.6%), a move that comes in response to Illumina's (ILMN+0.8%) recently disclosed competing bid earlier this month that was rejected by the life sciences company. BGI's tender offer now expires on December 14.